Congress of the ESCMID 2026 will take place from April 17 to 21, 2026, in Munich, Germany.
From 17 to 21 April 2026
An ANRS MIE session, co-organised with the German Center for Infection Research (DZIF), will be held on the theme “Shaping the future of West Nile virus research in Europe.”
This session will focus on defining the future research priorities for West Nile Virus (WNV) in Europe, emphasising the need for stronger European scientific collaboration. By convening experts from virology, entomology, ecology and climate research, clinical research, and public health, the session will explore how coordinated and complementary research efforts can accelerate our understanding of WNV dynamics and improve epidemic preparedness specifically in the European context.
A particular focus will be placed on France and Germany, where recent increases in WNV circulation highlight shared scientific challenges – from improving genomic surveillance and vector studies to refining clinical characterisation, modeling transmission, and evaluating innovative diagnostic and preventive tools. These two countries offer a unique opportunity to develop aligned research strategies and comparative studies that can benefit the wider European landscape of vector-borne diseases.
The overall objective is to outline a joint research agenda capable of supporting earlier detection, advancing mechanistic knowledge, and informing more effective interventions.
CHAIRS : Marylyn ADDO, University Medical Center Hamburg-Eppendorf (UKE), German Center for Infection Research (DZIF), Germany ; Eric D’ORTENZIO, ANRS Emerging infectious diseases, France ; Anna PAPA-KONIDARI, Aristotle university school of medicine, Greece
Leading experts in infectious diseases and clinical microbiology are gathering at ESCMID Global to exchange ideas and explore the latest innovations. It is also an opportunity to learn more about the research work funded by ANRS MIE.
|
Amandine Caillault |
Emergence and persistence of RSV-B resistant variants under monoclonal antibody Pressure: Evidence in a 3D human airway model |
|
Slim Fourati |
Real-world emergence of nirsevimab resistance in RSV-B breakthrough infections |
|
Cloé Grosbois |
How nasal host-based markers can improve the Diagnosis of Respiratory Viral Infections even in immunosenescent subjects? |
|
Eddy Kinganda Lusamaki |
Sustained mpox clade I human-to-human spread in DRC calls for continuous variant monitoring |
|
Raphaël Mérilleau Dusart |
Optimisation and multimodal characterisation of an in vitro Mycobacterium tuberculosis granuloma model |
|
William Mouton |
Critical COVID-19 unveils the link between viral particle blood dissemination and prolonged Type I Interferon |
|
Tom Perisse |
History of vaccination and infection shapes the humoral response to SARS-CoV-2 through IgG4 class switching |
|
Laurent Softic |
Commercial serological assays as reliable surrogates for neutralisation in monitoring RSV vaccine responses in immunocompromised patients |
5-Year Immunogenicity of 3 Ebola Vaccine Strategies in West Africa par Abdoul Beavogui, et al. And the PREVAC study team.
Pathogens and people: modelling epidemics for preparedness
This presentation will focus on non-traditional data in modelling for pandemic preparedness and response.